Spontaneous regression of subretinal choroidal neovascularisation in a patient with AMD
Author: Ilias Papandreou (Greece)
To present a case of spontaneous regression of choroidal neovascularisation after interruption of anti-VEGF treatment
The patient was reviewed at the Athens Eye Center
A 69-year-old presented in 2019 with bilateral choroidal neovascularization caused by age related macular degeneration (AMD). Visual acuity was 6/18 in both eyes. He underwent treatment with intravitreal Lucentis injections in both eyes and cataract surgery.
Subretinal and intravitreal fluid resolved and best corrected visual acuity improved to 6/12 in both eyes. The subretinal tissue remain unchanged throughout the treatment with Lucentis. The patient was seen in March 2020 and planned for further anti-VEGF treatment because of new fluid accumulation. He was lost to follow up because of the pandemic and resurfaced in April 2021. At that time the subretinal tissue had completely regressed in the right eye and remained unchanged in the left eye.
It is unclear whether this was an automatic regression of choroidal neovascularization or different pathology was at play.
Secretariat Address European Society of Retina Specialists Ground Floor, The Apex Building Blackthorn Road
Sandyford Business Park
Co Dublin, D18 H6K2